Literature DB >> 15532722

Inhibition of nuclear factor-kappa B prevents staphylococcal enterotoxin A-induced fever.

Dong-Zi Shao1, Jie-Jen Lee, Wu-Tein Huang, Jyh-Fei Liao, Mao-Tsun Lin.   

Abstract

It has been shown that staphylococcal enterotoxin A (SEA) acts through human peripheral blood mononuclear cells (PBMC) to stimulate synthesis or release of pyrogenic cytokines. Nuclear factor-kappa B (NF-kappaB) is thought to play an important role in inflammatory responses through the regulation of genes encoding pro-inflammatory cytokines. The purpose of the present study was to determine whether the NF-kappaB mechanisms in human PBMC are involved in SEA-induced fever. Western blot evaluation revealed SEA was able to induce nuclear translocation of NF-kappaB from cytosol to nucleus in PBMC, which could be abolished by a NF-kappaB inhibitor such as pyrrolidine dithiocarbamate (PDTC), sodium pyrithione (Pyri), N-acetyl-L-cysteine (NAC), or curcumin (Cur). Electrophoretic mobility shift assay also showed that the NF-kappaB DNA-binding activity was increased in the SEA-treated PBMC. Again, the SEA-induced increased NF-kappaB binding activity was significantly attenuated by either PDTC, Pyri, NAC or Cur. The pyrogenic responses to supernatant fluids obtained from human PBMC stimulated with SEA were associated with increased levels of interleukin 1-beta (IL-1beta), IL-6, and tumor necrosis factor-alpha (TNF-alpha) in the supernatant fluids. Both the fever and the increased levels of IL-1beta, IL-6, and TNF-alpha in supernatant fluids obtained from the SEA-stimulated PBMC were decreased by incubating SEA-PBMC with either PDTC, Pyri, NAC, or Cur. Furthermore, the fever induced by systemic or central administration of SEA in rabbits were attenuated by pre-treatment with an systemic or central dose of either PDTC, Pyri, NAC, or Cur. The data indicate that inhibition of NF-kappaB prevents SEA-induced fever.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15532722     DOI: 10.1023/b:mcbi.0000038233.20276.e0

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  31 in total

Review 1.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

Authors:  M Karin; Y Ben-Neriah
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 2.  Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer.

Authors:  Y Yamamoto; R B Gaynor
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

3.  The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-kappa B-mediated inhibition.

Authors:  G Franzoso; V Bours; S Park; M Tomita-Yamaguchi; K Kelly; U Siebenlist
Journal:  Nature       Date:  1992-09-24       Impact factor: 49.962

4.  Regulation of the genes encoding interleukin-6, its receptor, and gp130 in the rat brain in response to the immune activator lipopolysaccharide and the proinflammatory cytokine interleukin-1beta.

Authors:  L Vallières; S Rivest
Journal:  J Neurochem       Date:  1997-10       Impact factor: 5.372

5.  Staphylococcal enterotoxin A-induced fever is associated with increased circulating levels of cytokines in rabbits.

Authors:  W T Huang; M T Lin; S J Won
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

6.  Lipid extract of Mycoplasma penetrans proteinase K-digested lipid-associated membrane proteins rapidly activates NF-kappaB and activator protein 1.

Authors:  S H Feng; S C Lo
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

Review 7.  Pyrogen sensing and signaling: old views and new concepts.

Authors:  C M Blatteis; E Sehic; S Li
Journal:  Clin Infect Dis       Date:  2000-10       Impact factor: 9.079

Review 8.  Superantigens and their potential role in human disease.

Authors:  B L Kotzin; D Y Leung; J Kappler; P Marrack
Journal:  Adv Immunol       Date:  1993       Impact factor: 3.543

9.  Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide.

Authors:  J Stadler; M Stefanovic-Racic; T R Billiar; R D Curran; L A McIntyre; H I Georgescu; R L Simmons; C H Evans
Journal:  J Immunol       Date:  1991-12-01       Impact factor: 5.422

10.  Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP, and lipopolysaccharide.

Authors:  U Dendorfer; P Oettgen; T A Libermann
Journal:  Mol Cell Biol       Date:  1994-07       Impact factor: 4.272

View more
  8 in total

1.  N-Acetylcysteine prevents baker's-yeast-induced inflammation and fever.

Authors:  Ana Paula Oliveira Ferreira; Juliana Saibt Martins Pasin; André Luis Lopes Saraiva; Viviane Ratzlaff; Mateus Fortes Rossato; Rosália Andrighetto; Maribel Antonello Rubin; Juliano Ferreira; Carlos Fernando Mello
Journal:  Inflamm Res       Date:  2011-11-08       Impact factor: 4.575

2.  Serum Metabolomics Based on GC-MS Reveals the Antipyretic Mechanism of Ellagic Acid in a Rat Model.

Authors:  Fengfeng Xie; Liba Xu; Hua Zhu; Yinlan Li; Lizhen Nong; Yaling Chen; Yanfang Zeng; Sijie Cen
Journal:  Metabolites       Date:  2022-05-25

3.  Tetramethylpyrazine decreases hypothalamic glutamate, hydroxyl radicals and prostaglandin-E2 and has antipyretic effects.

Authors:  Chin-Hong Chang; Wu-Tein Huang; Cheng-Hsing Kao; Sheng-Hsien Chen; Cheng-Hsien Lin
Journal:  Inflamm Res       Date:  2013-03-23       Impact factor: 4.575

4.  Epithelial proinflammatory response and curcumin-mediated protection from staphylococcal toxic shock syndrome toxin-1.

Authors:  Matthew M Schaefers; Laura M Breshears; Michele J Anderson; Ying-Chi Lin; Alex E Grill; Jayanth Panyam; Peter J Southern; Patrick M Schlievert; Marnie L Peterson
Journal:  PLoS One       Date:  2012-03-14       Impact factor: 3.240

5.  Amelioration of ultraviolet-induced photokeratitis in mice treated with astaxanthin eye drops.

Authors:  Anton Lennikov; Nobuyoshi Kitaichi; Risa Fukase; Miyuki Murata; Kousuke Noda; Ryo Ando; Takeshi Ohguchi; Tetsuya Kawakita; Shigeaki Ohno; Susumu Ishida
Journal:  Mol Vis       Date:  2012-02-14       Impact factor: 2.367

6.  Pharmacogenomic Characterization and Isobologram Analysis of the Combination of Ascorbic Acid and Curcumin-Two Main Metabolites of Curcuma longa-in Cancer Cells.

Authors:  Edna Ooko; Onat Kadioglu; Henry J Greten; Thomas Efferth
Journal:  Front Pharmacol       Date:  2017-02-02       Impact factor: 5.810

7.  T-5224, a selective inhibitor of c-Fos/activator protein-1, improves survival by inhibiting serum high mobility group box-1 in lethal lipopolysaccharide-induced acute kidney injury model.

Authors:  Mari Ishida; Masaaki Ueki; Jun Morishita; Masaki Ueno; Shunichi Shiozawa; Nobuhiro Maekawa
Journal:  J Intensive Care       Date:  2015-11-14

8.  Staphylococcal Enterotoxin A Induces Intestinal Barrier Dysfunction and Activates NLRP3 Inflammasome via NF-κB/MAPK Signaling Pathways in Mice.

Authors:  Chunmei Liu; Kunmei Chi; Meng Yang; Na Guo
Journal:  Toxins (Basel)       Date:  2022-01-01       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.